Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Healthequity (HQY) EPS (Weighted Average and Diluted) (2016 - 2026)

Healthequity has reported EPS (Weighted Average and Diluted) over the past 14 years, most recently at $0.58 for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 93.33% year-over-year to $0.58; the TTM value through Jan 2026 reached $2.46, up 125.69%, while the annual FY2026 figure was $2.46, 125.69% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 was $0.58 at Healthequity, down from $0.59 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.68 in Q3 2025 and troughed at -$0.39 in Q1 2022.
  • A 5-year average of $0.21 and a median of $0.17 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 657.14% in 2022 and later soared 12220.86% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.02 in 2022, then skyrocketed by 950.0% to $0.17 in 2023, then crashed by 64.71% to $0.06 in 2024, then soared by 883.33% to $0.59 in 2025, then dropped by 1.69% to $0.58 in 2026.
  • Business Quant data shows EPS (Weighted Average and Diluted) for HQY at $0.58 in Q1 2026, $0.59 in Q4 2025, and $0.68 in Q3 2025.